Xiangyu Zhou

2.7k total citations · 1 hit paper
89 papers, 2.1k citations indexed

About

Xiangyu Zhou is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xiangyu Zhou has authored 89 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 21 papers in Cancer Research and 19 papers in Surgery. Recurrent topics in Xiangyu Zhou's work include Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (11 papers) and Pancreatitis Pathology and Treatment (9 papers). Xiangyu Zhou is often cited by papers focused on Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (11 papers) and Pancreatitis Pathology and Treatment (9 papers). Xiangyu Zhou collaborates with scholars based in China, Japan and United States. Xiangyu Zhou's co-authors include Yanzheng He, Xuemei He, Zhiqiang Liu, Jing Huang, Feng Jiang, Isao Naguro, Hidenori Ichijo, Kengo Watanabe, Xian Deng and Chunhong Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.

In The Last Decade

Xiangyu Zhou

86 papers receiving 2.0k citations

Hit Papers

CircRNA DICAR as a novel endogenous regulator for diabeti... 2023 2026 2024 2025 2023 25 50 75

Peers

Xiangyu Zhou
Xiangyu Zhou
Citations per year, relative to Xiangyu Zhou Xiangyu Zhou (= 1×) peers Xiaonan Liu

Countries citing papers authored by Xiangyu Zhou

Since Specialization
Citations

This map shows the geographic impact of Xiangyu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyu Zhou more than expected).

Fields of papers citing papers by Xiangyu Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyu Zhou. The network helps show where Xiangyu Zhou may publish in the future.

Co-authorship network of co-authors of Xiangyu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyu Zhou. A scholar is included among the top collaborators of Xiangyu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyu Zhou. Xiangyu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Dai, Xufang, Yanbing Chen, Chengheng Wu, et al.. (2025). Hybrid Lipoplex Boosts Neuron‐Microglia Crosstalk for Treatment of Alzheimer's Disease through A β ‐Targeted‐Autophagy and ApoE2 Gene Supplementation. Advanced Materials. 37(27). e2418560–e2418560. 3 indexed citations
3.
Wu, Haoran, et al.. (2025). Thyroid hormone ameliorates ursodeoxycholic acid-induced heart damage in zebrafish embryos. Life Sciences. 377. 123716–123716.
4.
Zhang, Jie, Xueqin Wang, Jun Tang, et al.. (2024). Biomimetic nanoplatform treats myocardial ischemia/reperfusion injury by synergistically promoting angiogenesis and inhibiting inflammation. Colloids and Surfaces B Biointerfaces. 243. 114159–114159. 9 indexed citations
5.
Zheng, Xiu, Hong Yang, Zongquan Zhang, et al.. (2024). pH-responsive size-adjustable liposomes induce apoptosis of fibroblasts and macrophages for rheumatoid arthritis treatment. Acta Biomaterialia. 179. 256–271. 27 indexed citations
6.
Liu, Yan, Meiling Zhou, Xueqin Wang, et al.. (2024). Reprogramming monocytes into M2 macrophages as living drug depots to enhance treatment of myocardial ischemia-reperfusion injury. Journal of Controlled Release. 374. 639–652. 13 indexed citations
7.
Fan, Chao, Zhen Liu, Jili Wu, et al.. (2024). Alendronate-functionalized polymeric micelles target icaritin to bone for mitigating osteoporosis in a rat model. Journal of Controlled Release. 376. 37–51. 9 indexed citations
8.
Wu, Fei, et al.. (2024). Thyrotropin induces atherosclerosis by upregulating large conductance Ca2+-activated K+ channel subunits. Molecular and Cellular Endocrinology. 583. 112145–112145.
9.
Chang, Lijia, Tong Wang, Youge Qu, et al.. (2024). Identification of novel endoplasmic reticulum-related genes and their association with immune cell infiltration in major depressive disorder. Journal of Affective Disorders. 356. 190–203. 3 indexed citations
10.
Wang, Chenglong, Zongquan Zhang, Xi Yang, et al.. (2024). Advances in nanotherapeutics for tumor treatment by targeting calcium overload. Colloids and Surfaces B Biointerfaces. 245. 114190–114190. 7 indexed citations
11.
Chen, Zhen‐Yu, Zhongbing Liu, Jun Wei, et al.. (2023). Long-Circulating Lipid Nanospheres Loaded with Flurbiprofen Axetil for Targeted Rheumatoid Arthritis Treatment. International Journal of Nanomedicine. Volume 18. 5159–5181. 4 indexed citations
12.
Wang, Changguang, Jun Jiang, Jianming Wu, et al.. (2023). Nanocomposite hydrogel to deliver the immunomodulator lenalidomide and anti-inflammatory hesperidin locally to joints affected by rheumatoid arthritis. Chemical Engineering Journal. 476. 146270–146270. 9 indexed citations
13.
Yuan, Qiong, Fan Yang, Dan Yan, et al.. (2023). CircRNA DICAR as a novel endogenous regulator for diabetic cardiomyopathy and diabetic pyroptosis of cardiomyocytes. Signal Transduction and Targeted Therapy. 8(1). 99–99. 75 indexed citations breakdown →
14.
Wu, Fei, et al.. (2022). Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/ERK signaling pathway. Molecular Biology Reports. 49(5). 3793–3802. 5 indexed citations
15.
Wang, Chenglong, et al.. (2022). Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases. Asian Journal of Pharmaceutical Sciences. 18(1). 100772–100772. 65 indexed citations
16.
He, Xuemei, et al.. (2021). Aberrant expression of five miRNAs in papillary thyroid carcinomas. Journal of Clinical Laboratory Analysis. 35(9). e23907–e23907. 8 indexed citations
17.
Q, Hu, et al.. (2021). Programmed Cell Death Ligand 1‐Transfected Mouse Bone Marrow Mesenchymal Stem Cells as Targeted Therapy for Rheumatoid Arthritis. BioMed Research International. 2021(1). 5574282–5574282. 8 indexed citations
18.
Liu, Zhiqiang, et al.. (2018). Gli2 Mediated Activation of Hedgehog Signaling Attenuates Acute Pancreatitis via Balancing Inflammatory Cytokines in Mice. Cellular Physiology and Biochemistry. 48(1). 120–130. 9 indexed citations
19.
He, Xuemei, Yinqiang Zheng, Yong Liu, et al.. (2017). MiR‐146a protects small intestine against ischemia/reperfusion injury by down‐regulating TLR4/TRAF6/NF‐κB pathway. Journal of Cellular Physiology. 233(3). 2476–2488. 66 indexed citations
20.
Ding, Junli, Zong‐Guang Zhou, Xiangyu Zhou, et al.. (2012). Attenuation of Acute Pancreatitis by Peroxisome Proliferator-Activated Receptor-α in Rats. Pancreas. 42(1). 114–122. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026